Oculys Overview
- Founded
- 2011
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $3.15M
Oculys General Information
Description
Developer of a health informatics technology designed to simplify the complexity in healthcare by relentlessly pursuing innovation through collaboration and software technology. The company's technology provides visibility of critical information as it happens, resulting in reduced patient length of stay, improved patient satisfaction and improved margins and can consolidate essential hospital operational and utilisation data from across systems into one view, in real-time, enabling communities and healthcare professionals to get practical tools on a daily basis.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Outcome Management (Healthcare)
Other Healthcare Technology Systems
Parent Company
Primary Office
- 204-609 Kumpf Drive
- Waterloo, Ontario N2V 1K8
- Canada
Oculys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 21-Nov-2019 | $3.15M | 00.000 | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 03-Nov-2016 | Completed | Generating Revenue |
Oculys Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bruce Gordon | Oculys | Board Member | 000 0000 |
| Michael Dye | Oculys | Board Member | 000 0000 |
| Thomas Hunter | Self | Board Member | 000 0000 |
| Wilson Parasiuk | Self | Chairman | 000 0000 |
Oculys Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| The Lazaridis Institute | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |